Susquehanna Fundamental Investments LLC Invests $1.68 Million in Trupanion, Inc. $TRUP

Key Points

• Susquehanna Fundamental Investments purchased 67,780 Trupanion shares worth approximately $1.68 million, representing about 0.15% of the pet insurer.
• Analyst sentiment remains cautious: Trupanion has an average “Hold” rating from MarketBeat, with one Buy and five Hold ratings and a consensus price target of $39.20.
• Trupanion exceeded quarterly expectations, reporting $0.16 EPS versus $0.11 expected and $392.93 million in revenue, up 11.1% year over year. The stock opened at $27.88, down 4.4%, while insiders have sold $503,038 worth of shares over the past 90 days.

Susquehanna Fundamental Investments LLC purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 67,780 shares of the financial services provider's stock, valued at approximately $1,679,000. Susquehanna Fundamental Investments LLC owned about 0.15% of Trupanion at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Kelleher Financial Advisors purchased a new position in shares of Trupanion during the second quarter valued at approximately $42,000. Parallel Advisors LLC raised its holdings in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock worth $47,000 after buying an additional 1,722 shares during the period. Kemnay Advisory Services Inc. bought a new stake in shares of Trupanion during the 4th quarter worth approximately $64,000. Quantbot Technologies LP bought a new stake in shares of Trupanion during the 2nd quarter worth approximately $89,000. Finally, Advisory Services Network LLC purchased a new position in Trupanion during the 3rd quarter valued at $160,000.

Wall Street Analyst Weigh In

Several brokerages have commented on TRUP. Weiss Ratings raised Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, August 26th. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research note on Wednesday, July 15th. Piper Sandler cut shares of Trupanion from an "overweight" rating to a "neutral" rating and cut their price target for the stock from $45.00 to $32.00 in a report on Wednesday, August 26th. Stifel Nicolaus raised their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a "hold" rating in a research note on Thursday, August 20th. Finally, Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, Trupanion presently has an average rating of "Hold" and a consensus target price of $39.20.

Trupanion Trading Down 4.4%

TRUP opened at $27.88 on Wednesday. The stock's fifty day moving average is $27.21 and its two-hundred day moving average is $25.89. The company has a market capitalization of $1.22 billion, a P/E ratio of 52.60, a PEG ratio of 1.97 and a beta of 1.45. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. During the same period in the previous year, the company posted $0.22 EPS. Trupanion's revenue was up 11.1% on a year-over-year basis. Analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 6,111 shares of Trupanion stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total value of $183,391.11. Following the completion of the sale, the chief financial officer directly owned 4,230 shares in the company, valued at $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the company's stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president directly owned 78,062 shares of the company's stock, valued at approximately $1,717,364. This trade represents a 7.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 18,720 shares of company stock worth $503,038. Corporate insiders own 5.58% of the company's stock.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.